瘤内及瘤周影像组学列线图术前预测非小细胞肺癌脉管侵犯及总生存
本研究纳入240例来自本机构的非小细胞肺癌患者(按6:4随机分为训练集145例和内部验证集95例)及65例癌症影像档案库外部验证集患者,提取瘤内及瘤周3、6、9 mm区域的CT影像组学特征。GPTV9模型预测脉管侵犯的AUC在训练集、内部验证集和外部验证集分别为0.82、0.75和0.67;结合临床独立预测因素(吸烟和临床分期)与GPTV9-Radscore的列线图AUC分别为0.89、0.83和0.66。病理脉管侵犯、GPTV9-Radscore预测的脉管侵犯和Nomoscore预测的脉管侵犯均与较差的总生存相关(p < 0.05)。
要点
- 术前CT影像组学列线图可预测NSCLC脉管侵犯和总生存,辅助制定个体化治疗策略。
- 瘤周9 mm区域(GPTV9)的影像组学模型预测脉管侵犯性能优于瘤内及瘤周3、6 mm模型。
- 列线图结合GPTV9-Radscore与临床独立预测因素(吸烟、临床分期),性能优于临床模型。
诊断标准与关键数值
- GPTV9影像组学模型预测脉管侵犯的AUC在训练集、内部验证集和外部验证集分别为0.82、0.75和0.67。
- 列线图(结合临床独立预测因素和GPTV9-Radscore)预测脉管侵犯的AUC在训练集、内部验证集和外部验证集分别为0.89、0.83和0.66。
- 临床模型中吸烟和临床分期为独立预测因素。
临床应用与阅片要点
- 术前可基于CT提取瘤内及瘤周9 mm区域的影像组学特征计算Radscore,结合吸烟和临床分期使用列线图预测脉管侵犯风险。
- GPTV9-Radscore或Nomoscore预测的脉管侵犯与较差的总生存相关,提示可用于术前风险分层。
- 列线图在外部验证集AUC为0.66,提示外推性能有限,临床应用时需结合其他临床信息综合判断。
局限性
- 外部验证集AUC(0.66)明显低于训练集(0.89)和内部验证集(0.83),提示模型泛化能力有限。
- 研究为回顾性设计,样本来自单中心及公共数据库,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the predictive value of intratumoral and peritumoral radiomics and radiomics nomogram for preoperative lymphovascular invasion (LVI) status and overall survival (OS) in patients with non-small cell lung cancer (NSCLC).
METHODS: In total, 240 NSCLC patients from our institution were randomly divided into the training cohort (n = 145) and internal validation cohort (n = 95) with a ratio of 6:4, and 65 patients from the Cancer Imaging Archive were enrolled as the external validation cohort. We extracted 1217 CT-based radiomics features from the gross tumor volume (GTV) and gross tumor volume incorporating peritumoral 3, 6, and 9 mm regions (GPTV3, GPTV6, GPTV9). A radiomics nomogram based on clinical independent predictors and radiomics score (Radscore) of the best radiomics model was constructed. The correlation between factors and OS was evaluated with the Kaplan-Meier survival analysis and Cox proportional hazards regression analysis.
RESULTS: Compared with GTV, GPTV3, and GPTV6 radiomics models, GPTV9 radiomics model exhibited better prediction performance with the AUCs of 0.82, 0.75, and 0.67 in the training, internal validation, and external validation cohorts, respectively. In the clinical model, smoking and clinical stage were independent predictors. The nomogram incorporating independent predictors and GPTV9-Radscore was clinically useful, with the AUCs of 0.89, 0.83, and 0.66 in three cohorts. Pathological LVI, GPTV9-Radscore-predicted, and Nomoscore-predicted LVI were associated with poor OS (p < 0.05).
CONCLUSIONS: CT-based radiomics nomogram can predict LVI and OS in patients with NSCLC and may help in making personalized treatment strategies before surgery.
KEY POINTS: • Compared with GTV, GPTV3, and GPTV6 radiomics models, GPTV9 radiomics model showed better prediction performance for LVI status in NSCLC. • The radiomics nomogram based on GPTV9 radiomics features and clinical independent predictors could effectively predict LVI status and OS in NSCLC and outperformed the clinical model. • The radiomics nomogram had a wider scope of clinical application.
引用
- Chen, Shao, Xue, et al. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer. Eur Radiol. 2022. PMID: 36064979. doi:10.1007/s00330-022-09109-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。